Press release content from Globe Newswire. The AP news staff was not involved in its creation. Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition MYCONIC CAPITAL CORP.April 22, 2021 GMT VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the “Company” or “Myconic”) is pleased to announce that, further to its press release of March 10, 2021, it has completed the acquisition of all of the issued and outstanding equity of Mindscape Ketamine & Infusions Ther...